Invention Grant
- Patent Title: Mitrecin a polypeptide with antimicrobial activity
-
Application No.: US15400707Application Date: 2017-01-06
-
Publication No.: US09987338B2Publication Date: 2018-06-05
- Inventor: Michael Heath Farris
- Applicant: The MITRE Corporation
- Applicant Address: US VA McClean
- Assignee: THE MITRE CORPORATION
- Current Assignee: THE MITRE CORPORATION
- Current Assignee Address: US VA McClean
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K9/00 ; A61K9/06 ; C12N9/52 ; A01N37/46 ; A23L2/52 ; A23L33/10

Abstract:
The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
Public/Granted literature
- US20170189498A1 MITRECIN A POLYPEPTIDE WITH ANTIMICROBIAL ACTIVITY Public/Granted day:2017-07-06
Information query
IPC分类: